News
If phase 3 trials of MM120 (lysergide d-tartrate) for anxiety and depression are successful, could the LSD-based drug become ...
This is a mistake. GLP-1s appear to modify addictive brain pathways that are activated by ultraformulated foods, helping ...
The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...
The U.S. Food and Drug Administration said Tuesday it will expand its use of unannounced inspections at foreign manufacturing ...
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a ...
Trump told Time magazine in December he would not restrict access to abortion medication. On the campaign trail, the ...
U.S. President Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve ...
New Jersey and 17 other states argued that the cuts of 10,000 employees essentially shutters programs that can only be ended ...
The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...
A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or ...
Food and Drug Administration Commissioner Marty Makary, M.D., spoke about the need to shorten the length of the drug approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results